Daito Pharmaceutical Co., Ltd.
4577 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 富山市八日町３２６番地
- Website:
- https://www.eng.daitonet.co.jp/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Daito Pharmaceutical Co., Ltd. is a prominent Japanese company dedicated to the manufacture of high-quality pharmaceuticals, ranging from active pharmaceutical ingredients (APIs) to finished formulation products. With a strong commitment to quality assurance and sustainability, Daito emphasizes rigorous manufacturing and quality management processes to ensure that its products are safe and reliable for consumers. The company's mission is to promote the health and well-being of individuals by providing consistent access to superior pharmaceutical solutions. Through its dedication to corporate social responsibility, Daito aims to contribute positively to society, ensuring it remains a trusted choice for clients and partners in the healthcare industry.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-12 09:16 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.3 KB | |
| 2025-05-13 09:22 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 26.0 KB | |
| 2025-04-11 08:53 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 25.3 KB | |
| 2025-03-12 08:08 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.7 KB | |
| 2025-02-13 08:56 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 24.2 KB | |
| 2025-01-17 09:04 |
Inside Information Statement
臨時報告書
|
Japanese | 34.3 KB | |
| 2025-01-10 08:56 |
Regulatory News Service
確認書
|
Japanese | 8.3 KB | |
| 2025-01-10 08:54 |
Interim Report
半期報告書－第83期(2024/06/01－2025/05/31)
|
Japanese | 194.9 KB | |
| 2024-09-02 08:00 |
Inside Information Statement
臨時報告書
|
Japanese | 21.8 KB | |
| 2024-08-30 07:43 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-08-30 07:41 |
Internal Control over Financial Reporting
内部統制報告書－第82期(2023/06/01－2024/05/31)
|
Japanese | 22.1 KB | |
| 2024-08-30 07:38 |
Annual Report
有価証券報告書－第82期(2023/06/01－2024/05/31)
|
Japanese | 1.3 MB | |
| 2024-08-28 09:43 |
Inside Information Statement
臨時報告書
|
Japanese | 20.4 KB | |
| 2024-04-12 09:17 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-04-12 09:15 |
Quarterly Report
四半期報告書－第82期第3四半期(2023/12/01－2024/02/29)
|
Japanese | 149.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |